These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

366 related items for PubMed ID: 9217760

  • 1. Distinction of idiopathic Parkinson's disease from multiple-system atrophy by stimulation of growth-hormone release with clonidine.
    Kimber JR, Watson L, Mathias CJ.
    Lancet; 1997 Jun 28; 349(9069):1877-81. PubMed ID: 9217760
    [Abstract] [Full Text] [Related]

  • 2. Growth hormone response to arginine test distinguishes multiple system atrophy from Parkinson's disease and idiopathic late-onset cerebellar ataxia.
    Pellecchia MT, Pivonello R, Salvatore E, Faggiano A, Barone P, De Michele G, Lombardi G, Colao A, Filla A.
    Clin Endocrinol (Oxf); 2005 Apr 28; 62(4):428-33. PubMed ID: 15807873
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Is clonidine growth hormone stimulation a good test to differentiate multiple system atrophy from idiopathic Parkinson's disease?
    Tranchant C, Guiraud-Chaumeil C, Echaniz-Laguna A, Warter JM.
    J Neurol; 2000 Nov 28; 247(11):853-6. PubMed ID: 11151417
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Beta-adrenoceptor expression on circulating mononuclear cells of idiopathic Parkinson's disease and autonomic failure patients before and after reduction of central sympathetic outflow by clonidine.
    Zoukos Y, Thomaides T, Pavitt DV, Cuzner ML, Mathias CJ.
    Neurology; 1993 Jun 28; 43(6):1181-7. PubMed ID: 8170565
    [Abstract] [Full Text] [Related]

  • 7. Physiological, pharmacological and neurohormonal assessment of autonomic function in progressive supranuclear palsy.
    Kimber J, Mathias CJ, Lees AJ, Bleasdale-Barr K, Chang HS, Churchyard A, Watson L.
    Brain; 2000 Jul 28; 123 ( Pt 7)():1422-30. PubMed ID: 10869054
    [Abstract] [Full Text] [Related]

  • 8. Diagnosing multiple system atrophy with greater accuracy: combined analysis of the clonidine-growth hormone test and external anal sphincter electromyography.
    Lee EA, Kim BJ, Lee WY.
    Mov Disord; 2002 Nov 28; 17(6):1242-7. PubMed ID: 12465063
    [Abstract] [Full Text] [Related]

  • 9. Growth hormone response to clonidine in central and peripheral primary autonomic failure.
    Thomaides TN, Chaudhuri KR, Maule S, Watson L, Marsden CD, Mathias CJ.
    Lancet; 1992 Aug 01; 340(8814):263-6. PubMed ID: 1353191
    [Abstract] [Full Text] [Related]

  • 10. Growth hormone responses to growth hormone-releasing hormone and clonidine before and after erythropoietin therapy in CAPD patients.
    Díez J, Iglesias P, Sastre J, Méndez J, Selgas R, Gómez-Pan A.
    Nephron; 1996 Aug 01; 74(3):548-54. PubMed ID: 8938679
    [Abstract] [Full Text] [Related]

  • 11. Hemodynamic effects of clonidine in two contrasting models of autonomic failure: multiple system atrophy and pure autonomic failure.
    Young TM, Asahina M, Watson L, Mathias CJ.
    Mov Disord; 2006 May 01; 21(5):609-15. PubMed ID: 16404729
    [Abstract] [Full Text] [Related]

  • 12. [Utility of the study of the vegetative nervous system in the differential diagnosis between Parkinson's disease and multiple system atrophy].
    Rouco I, Gómez JC, Lezcano E, Aniel-Quiroga MA, Velasco F, Barcena J, Pérez Bas M, Hurtado P, Cruz Lachén M, Zarranz JJ.
    Neurologia; 2006 Apr 01; 21(3):119-23. PubMed ID: 16575624
    [Abstract] [Full Text] [Related]

  • 13. The comparison of clonidine, arginine and both combined: a growth hormone stimulation test to differentiate multiple system atrophy from idiopathic Parkinson's disease.
    Zhang K, Zeng Y, Song C, Fu Y, Wan Q.
    J Neurol; 2010 Sep 01; 257(9):1486-91. PubMed ID: 20405138
    [Abstract] [Full Text] [Related]

  • 14. Hypothalamic versus pituitary dysfunction in Down's syndrome as cause of growth retardation.
    Castells S, Beaulieu I, Torrado C, Wisniewski KE, Zarny S, Gelato MC.
    J Intellect Disabil Res; 1996 Dec 01; 40 ( Pt 6)():509-17. PubMed ID: 9004111
    [Abstract] [Full Text] [Related]

  • 15. The arginine growth hormone stimulation test in bradykinetic-rigid parkinsonisms.
    Pellecchia MT, Longo K, Manfredi M, Lucetti C, Cossu G, Petrone A, Marconi R, Sensi M, Epifanio A, Eleopra R, Marchese R, Scaravilli T, Morgante L, Abbruzzese G, Bonuccelli U, Donati E, Pivonello R, Colao A, Barone P.
    Mov Disord; 2008 Jan 30; 23(2):190-4. PubMed ID: 18044703
    [Abstract] [Full Text] [Related]

  • 16. Multiple system atrophy is distinguished from idiopathic Parkinson's disease by the arginine growth hormone stimulation test.
    Pellecchia MT, Longo K, Pivonello R, Lucetti C, Marchese R, Spampani A, Manfredi M, Epifanio A, Sensi M, Scaravilli T, Bracco F, Eleopra R, Morgante L, Donati E, Marconi R, Abbruzzese G, Bonuccelli U, Zappia M, Colao A, Barone P.
    Ann Neurol; 2006 Nov 30; 60(5):611-615. PubMed ID: 16958123
    [Abstract] [Full Text] [Related]

  • 17. Growth hormone stimulation tests in the differential diagnosis of Parkinson's disease.
    Pellecchia MT, Pivonello R, Colao A, Barone P.
    Clin Med Res; 2006 Dec 30; 4(4):322-5. PubMed ID: 17210980
    [Abstract] [Full Text] [Related]

  • 18. Levodopa treatment does not affect low-dose apomorphine test in patients with Parkinson's disease.
    Happe S, Tings T, Helmschmied K, Neubert K, Wuttke W, Paulus W, Trenkwalder C.
    Mov Disord; 2004 Dec 30; 19(12):1511-5. PubMed ID: 15390061
    [Abstract] [Full Text] [Related]

  • 19. Clonidine GH stimulation test to differentiate MSA from idiopathic late onset cerebellar ataxia: a prospective, controlled study.
    Bonnard C, Wirth T, Gebus O, Fahrer P, Montaut S, Robelin L, Tuzin N, Tranchant C, Anheim M.
    J Neurol; 2020 Mar 30; 267(3):855-859. PubMed ID: 32034477
    [Abstract] [Full Text] [Related]

  • 20. Stimulation of growth-hormone release with clonidine does not distinguish individual cases of idiopathic Parkinson's disease from those with striatonigral degeneration.
    Strijks E, van't Hof M, Sweep F, Lenders JW, Oyen WJ, Horstink MW.
    J Neurol; 2002 Sep 30; 249(9):1206-10. PubMed ID: 12242540
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.